IAP inhibitors (Hoffmann-La Roche)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameIAP inhibitors (Hoffmann-La Roche)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInhibitor of apoptosis protein 3 inhibitorsCellular inhibitor of apoptosis protein 1 inhibitors
TargetsCellular inhibitor of apoptosis protein 1Inhibitor of apoptosis protein 3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHoffmann-La Roche Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHoffmann-La Roche Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A